Iovance Biotherapeutics Inc (NASDAQ:IOVA)

4.55
BATS BZX Real-Time Price
As of 12:46pm ET
 -0.01 / -0.22%
Today’s Change
4.41
Today|||52-Week Range
10.41
-28.87%
Year-to-Date
Why Shares of Iovance Biotherapeutics Jumped Monday
Sep 18 / MotleyFool.com - Paid Partner Content
Iovance (IOVA) Up Despite FDA's Delayed Decision on Melanoma Drug
Sep 15 / Zacks.com - Paid Partner Content
Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today
Sep 15 / MotleyFool.com - Paid Partner Content
Why Shares of Iovance Biotherapeutics Dropped Thursday
Sep 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close4.56
Today’s open4.68
Day’s range4.52 - 4.82
Volume113,041
Average volume (3 months)6,501,608
Market cap$1.2B
Data as of 12:46pm ET, 09/26/2023

Growth & Valuation

Earnings growth (last year)-11.42%
Earnings growth (this year)+7.35%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp+0.02+1.15%
ARVNArvinas Inc-0.04-0.16%
MORFMorphic Holding Inc-0.92-3.97%
AUPHAurinia Pharmaceutic...+0.02+0.25%
Data as of 12:48pm ET, 09/26/2023

Financials

Next reporting dateNovember 8, 2023
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$395.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Carlos, California

Forecasts